Chandler E. Gill

804 total citations
41 papers, 550 citations indexed

About

Chandler E. Gill is a scholar working on Neurology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Chandler E. Gill has authored 41 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Neurology, 7 papers in Cellular and Molecular Neuroscience and 7 papers in Psychiatry and Mental health. Recurrent topics in Chandler E. Gill's work include Neurological disorders and treatments (16 papers), Botulinum Toxin and Related Neurological Disorders (12 papers) and Parkinson's Disease Mechanisms and Treatments (11 papers). Chandler E. Gill is often cited by papers focused on Neurological disorders and treatments (16 papers), Botulinum Toxin and Related Neurological Disorders (12 papers) and Parkinson's Disease Mechanisms and Treatments (11 papers). Chandler E. Gill collaborates with scholars based in United States and France. Chandler E. Gill's co-authors include David Charles, Thomas L. Davis, Peter E. Konrad, Michael G. Tramontana, Mark J. Bliton, Fenna T. Phibbs, Anna Lia Molinari, Joseph S. Neimat, Katie Kompoliti and Peter Hedera and has published in prestigious journals such as Neurology, Archives of Physical Medicine and Rehabilitation and Movement Disorders.

In The Last Decade

Chandler E. Gill

37 papers receiving 522 citations

Peers

Chandler E. Gill

NEURO

CMN

NEURO

Harutomo Hasegawa United Kingdom

Romain Lefaucheur France

Róbert Fekete United States

Ines Debove Switzerland

Paresh K. Doshi India

Josué M. Avecillas-Chasín United States

Yuya Saito Japan

Florence Delecluse Belgium

Emanuele Spina Italy

Patricia Krause Germany

Harutomo Hasegawa United Kingdom

Chandler E. Gill

355 ×0.8

NEURO

229 ×1.3

CMN

145 ×2.0

51 ×1.0

NEURO

19 ×0.5

Citations per year, relative to Chandler E. Gill Chandler E. Gill (= 1×) peers Harutomo Hasegawa

Countries citing papers authored by Chandler E. Gill

Since Specialization

Citations

This map shows the geographic impact of Chandler E. Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chandler E. Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chandler E. Gill more than expected).

Fields of papers citing papers by Chandler E. Gill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chandler E. Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chandler E. Gill. The network helps show where Chandler E. Gill may publish in the future.

Co-authorship network of co-authors of Chandler E. Gill

This figure shows the co-authorship network connecting the top 25 collaborators of Chandler E. Gill. A scholar is included among the top collaborators of Chandler E. Gill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chandler E. Gill. Chandler E. Gill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gill, Chandler E., et al.. (2022). A New Pathologic KMT2B Variant Associated with Childhood Onset Dystonia Presenting as Variable Phenotypes among Family Members. Tremor and Other Hyperkinetic Movements. 12(1). 7–7. 2 indexed citations

Gill, Chandler E., Mallory L. Hacker, Maxim Turchan, et al.. (2020). Prevalence of Spasticity in Nursing Home Residents. Journal of the American Medical Directors Association. 21(8). 1157–1160. 7 indexed citations

Gill, Chandler E. & Katie Kompoliti. (2019). Clinical Features of Tourette Syndrome. Journal of Child Neurology. 35(2). 166–174. 25 indexed citations

Gill, Chandler E., et al.. (2018). Postseizure aphasia in Wernicke's encephalopathy: a case report and review of literature. Neuropsychiatric Disease and Treatment. Volume 14. 2593–2598. 2 indexed citations

Gill, Chandler E., et al.. (2018). Severe Necrotizing Myopathy Associated with Pembrolizumab for Urothelial Carcinoma (P3.456). Neurology. 90(15_supplement).

Gill, Chandler E., et al.. (2017). Neurological Complications of Therapeutic Monoclonal Antibodies: Trends from Oncology to Rheumatology. Current Neurology and Neuroscience Reports. 17(10). 75–75. 13 indexed citations

Tramontana, Michael G., Anna Lia Molinari, Peter E. Konrad, et al.. (2015). Neuropsychological Effects of Deep Brain Stimulation in Subjects with Early Stage Parkinson's Disease in a Randomized Clinical Trial. Journal of Parkinson s Disease. 5(1). 151–163. 24 indexed citations

Camalier, Corrie R., Peter E. Konrad, Chandler E. Gill, et al.. (2014). Methods for Surgical Targeting of the STN in Early-Stage Parkinsonâ€™s Disease. Frontiers in Neurology. 5. 25–25. 16 indexed citations

Charles, David, Peter E. Konrad, Joseph S. Neimat, et al.. (2014). Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease. Parkinsonism & Related Disorders. 20(7). 731–737. 95 indexed citations

10.

Charles, David, Christopher Tolleson, Thomas L. Davis, et al.. (2012). Pilot Study Assessing the Feasibility of Applying Bilateral Subthalamic Nucleus Deep Brain Stimulation in Very Early Stage Parkinson's Disease: Study Design and Rationale. Journal of Parkinson s Disease. 2(3). 215–223. 16 indexed citations

11.

Charles, David, Chandler E. Gill, Thomas L. Davis, et al.. (2011). Deep brain stimulation in early Parkinson’s disease: Enrollment experience from a pilot trial. Parkinsonism & Related Disorders. 18(3). 268–273. 36 indexed citations

12.

Gill, Chandler E., Peter E. Konrad, Thomas L. Davis, et al.. (2011). Deep Brain Stimulation for Early-Stage Parkinson’s Disease: An Illustrative Case. Neuromodulation Technology at the Neural Interface. 14(6). 515–522. 7 indexed citations

13.

Charles, David, Chandler E. Gill, Thomas L. Davis, Peter E. Konrad, & Alim‐Louis Benabid. (2008). Is deep brain stimulation neuroprotective if applied early in the course of PD?. Nature Clinical Practice Neurology. 4(8). 424–426. 37 indexed citations

14.

Chapman, Mary Ann, et al.. (2007). Comparison of Botulinum Neurotoxin Preparations for the Treatment of Cervical Dystonia. Clinical Therapeutics. 29(7). 1325–1337. 41 indexed citations

15.

Gill, Chandler E., Peter E. Konrad, Thomas L. Davis, & David Charles. (2007). Deep brain stimulation for Parkinson's disease: the Vanderbilt University Medical Center experience, 1998-2004.. PubMed. 100(4). 45–7. 17 indexed citations

16.

Gill, Chandler E., et al.. (2006). Difficulty in securing treatment for degenerative hip disease in a patient with Down syndrome: the gap remains open.. PubMed. 98(1). 93–6. 9 indexed citations

17.

Newman, William J., et al.. (2004). Botulinum toxin type A therapy during pregnancy. Movement Disorders. 19(11). 1384–1385. 47 indexed citations

18.

Charles, David, Bimal Padaliya, William J. Newman, et al.. (2004). Deep brain stimulation of the subthalamic nucleus reduces antiparkinsonian medication costs. Parkinsonism & Related Disorders. 10(8). 475–479. 39 indexed citations

19.

Gill, Chandler E., et al.. (1975). Report on Fall 1974 undergraduate enrollment in schools and colleges of pharmacy.. PubMed. 39(3). 346–55. 1 indexed citations

20.

Gill, Chandler E., et al.. (1975). Report on graduate enrollment fall 1974 and graduate programs offered in member colleges 1975-76.. PubMed. 39(3). 356–68. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact